Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
6
×
life sciences
national blog main
san diego blog main
6
×
boston blog main
boston top stories
fda
new york blog main
san diego top stories
national top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston
cancer
chronic kidney disease
dyne therapeutics
investing
ipo
myotonic dystrophy type 1
national
rare disease drugs
startups
abbvie
acceleron pharma
What
therapeutics
6
×
drug
ipo
medicines
biotechs
companies
company
dyne
genetic
life
million
muscle
raised
rare
science
week
agency
ago
aimmune
allergy
approval
approved
awarded
bacteria
bio
biopharma
black
brings
business
club
considering
continue
continued
crop
data
debut
developed
developing
diamond
diamond’s
Language
unset
Current search:
therapeutics
×
" clinical trials "
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M